The Economic Impact of the Introduction of Biosimilars in Inflammatory Bowel Disease. [electronic resource]
Producer: 20171107Description: 289-296 p. digitalISSN:- 1876-4479
- Adalimumab -- economics
- Biosimilar Pharmaceuticals -- economics
- Colitis, Ulcerative -- drug therapy
- Computer Simulation
- Crohn Disease -- drug therapy
- Drug Costs -- statistics & numerical data
- Drug Prescriptions -- statistics & numerical data
- Drug Substitution -- economics
- Gastrointestinal Agents -- economics
- Hospitalization -- economics
- Humans
- Infliximab -- economics
- Models, Economic
- Netherlands
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.